by Truveta staff | May 6, 2025 | Culture
This week we gathered with leaders across healthcare, public health, and life sciences at the 3rd annual Truveta Symposium. Truveta Symposium uniquely brings together leaders from life science, public health, and healthcare organizations to collaborate on health...
by Truveta staff | Apr 1, 2025 | Research
GLP-1 drugs like Ozempic and Zepbound are transforming obesity treatment, yet 40-85% of patients are plagued by adverse GI events—particularly women. New research from Olio Labs, using Truveta Data, reveals that women experience nausea and vomiting at significantly...
by Truveta staff | Jan 9, 2025 | Data
In the world of medical research, data drives discovery. But until recently, nearly 80% of data relevant to research has been hidden in clinical notes. These notes include detailed observations, symptoms, and treatment plans that are absent from the structured data...
by Truveta News | Jan 9, 2025 | News
Truveta was named a gold winner in Most Innovative Company of the Year for medium-sized companies (100-999 employees) in the Best in Biz Awards 2024, the only independent business awards program judged by editors and reporters from North American publications. The...
by Jay Nanduri | Dec 10, 2024 | Technology
In the final article in this series, I will share some thoughts on meeting the following challenge: How to rapidly support new AI scenarios and adjacencies through reuse and transfer learning? Truveta has diverse, multimodal, and up-to-date data on clinical...
